Using labels to limit AI misuse in health

on

 

Just as medications come with strictly regulated labels, so too should AI products in healthcare settings, argue a pair of AI and health researchers. Modelled on the approach of the US Food and Drug Administration, labels should include approved usage, potential side effects, warnings and precautions, use in specific populations, adverse reactions, unapproved usage, completed studies and ingredients of the algorithm. This kind of label “challenges adopters to consider how their use deviates from the prescribed uses and forces them to take responsibility”, write the authors.